Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 204,107 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $4.7M as of 2025-Q4. The position was decreased (-1.4% shares). RARE represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$4.7M
Current Shares
204,107
Total Value Change
-$2.6M
Total Shares Change
+27,298
Other major holders of RARE: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 204,107 |
-1.4% |
| $4.7M |
| 0.0% |
| $22.78 |
0 |
| 2025-Q3 | Decreased | 207,042 | -31.2% | $6.2M | 0.0% | $30.36 | 0 |
| 2025-Q2 | Increased | 300,962 | +29.5% | $10.9M | 0.0% | $36.52 | 35 |
| 2025-Q1 | Increased | 232,360 | +14.8% | $8.4M | 0.0% | $37.82 | 31 |
| 2024-Q4 | Increased | 202,376 | +13.8% | $8.5M | 0.0% | $42.27 | 31 |
| 2024-Q3 | Increased | 177,756 | +0.5% | $9.9M | 0.0% | $54.43 | 28 |
| 2024-Q2 | Increased | 176,809 | +35.7% | $7.3M | 0.0% | $41.10 | 36 |